date:Nov 28, 2018
://bit.ly/2DOBSfu)
The European Union last week effectively banned https://www.reuters.com/article/us-mylan-valsartan-united-states/mylan-recalls-batches-of-blood-pressure-medicine-in-u-s-idUSKCN1NP2I3 sales of valsartan made by the Mylan India unit after some batches were found to contain the same impurity, N-nitrosodiethylamine.
Teva has not received any reports of adverse events signaling a potential link or exposure to valsartan, the health regulator said.
Patients are advised to continue